Organization and Business (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2017
Cash provided from operating cash flows		$ (1,749,536)	$ (2,212,393)	$ 1,341,052	$ (8,692,450)	$ (7,118,337)
Accumulated losses	$ (37,644,572)	(30,569,764)		(37,644,572)	(30,569,764)
Cash equivalents and marketable securities	$ 7,899,804			7,899,804
Proceeds from issuance of common stock				799,185
Cash purchase price			$ 294,862			$ 294,862
Shares issued price per share			$ 6.90
Stock Purchase Agreement [Member]
Proceeds from issuance of common stock				20,000,000
Cash purchase price				20,000,000
June 3, 2019 [Member] | Stock Purchase Agreement [Member]
Issuance of unregistered common stock shares	1,583,743
Proceeds from issuance of common stock	$ 7,960,635
Circassia Pharmaceuticals PLC [Member]
Marketable securities	$ 5,600,000			5,600,000
Lincoln Park Capital Fund, LLC [Member]
Proceeds from issuance of common stock				1,173,810
Cash purchase price				$ 17,482,005
Number of stock issued and sold				250,000
Shares issued price per share	$ 4.70			$ 4.70